Masimo impressed with a robust earnings report driven by its healthcare segment, despite challenges from non-healthcare operations.Masimo (MASI -0.69%), a provider of noninvasive patient monitoring technology, released its fourth-quarter earnings for 2024, on Feb. 25, 2025. The results presented a mixed picture: strong performance was seen in its core healthcare segment, with revenue reaching $601 million, surpassing analyst expectations of$592 million. The company's non-GAAP earnings per share (EPS) were ...